Physician profile
Joanne Combs
NPI 1932652096
$907.22
in general payments reported to CMS, 2019-2025
13 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $180 · 2023: $177 · 2024: $166 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.85 | 2021-2025 | |
| Indivior INC. | $200.03 | 2022-2025 | Sublocade |
| Orexo US, INC. | $56.03 | 2022-2023 | Zubsolv |
| Alkermes, INC. | $51.53 | 2025 | Lybalvi |
| Pfizer INC. | $47.75 | 2021-2025 | |
| Braeburn INC. | $47.03 | 2023-2025 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.12 | 2025 | Caplyta |
| Hikma Pharmaceuticals USA | $42.00 | 2022 | |
| Upsher-Smith Laboratories LLC | $41.53 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.58 | 2023-2024 | Relistor, Xifaxan |
| Vanda Pharmaceuticals INC. | $25.88 | 2024 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $25.10 | 2023 | Auvelity |
| Lilly USA, LLC | $14.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.